187 related articles for article (PubMed ID: 14252013)
21. [Clinical study on the combined action of orphenadrine and thioproperazine: correction of neuroleptic impregnation and therapeutic synergism].
RUDRAUF J; CHALLOU C
Acta Neurol Psychiatr Belg; 1961 Jan; 61():103-9. PubMed ID: 13744502
[No Abstract] [Full Text] [Related]
22. [SOME REMARKS ON THE INDICATIONS FOR UK-738 (PONALIDE) AS A CORRECTOR OF EXTRAPYRAMIDAL DISORDERS DUE TO NEUROLEPTICS].
BORENSTEIN P; BLES G
Gaz Med Fr; 1964 May; 71():2075. PubMed ID: 14144655
[No Abstract] [Full Text] [Related]
23. THE DIENCEPHALIZATION OF THE REACTIVE DEPRESSION (THE SUICIDAL IMPLICATIONS OF EUPHEMISTIC NAMES).
MEERLOO JA
Am J Psychiatry; 1964 Oct; 121():376-7. PubMed ID: 14211413
[No Abstract] [Full Text] [Related]
24. [CLOPENTHIXOL (CIATYL). NEUROLEPTIC EFFECT WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS].
NOECKER G
Med Klin; 1964 May; 59():776-9. PubMed ID: 14225431
[No Abstract] [Full Text] [Related]
25. A NEW ANTI-TREMOR COMPOUND.
SHARKEY J
Br J Clin Pract; 1964 May; 18():261-4. PubMed ID: 14147731
[No Abstract] [Full Text] [Related]
26. [COMPLICATIONS OF NEUROLEPTICS].
NEHLIL J
Clinique (Paris); 1963 Oct; 58():595-9. PubMed ID: 14092600
[No Abstract] [Full Text] [Related]
27. [EARLY CLINICAL EVALUATION OF THE NEUROLEPTIC PROPERTIES OF A NEW COMPOUND: DIBENZOTHIAZEPINE].
DELAY J; DENIKER P; GINESTET D; P'ERON MAGNAN P
Ann Med Psychol (Paris); 1964 Oct; 122():402-7. PubMed ID: 14205902
[No Abstract] [Full Text] [Related]
28. TREATMENT OF DRUG-INDUCED PARKINSONISM: A COMPARISON BETWEEN UK-738, ORPHENADRINE, AND A PLACEBO IN A DOUBLE BLIND STUDY.
JENSEN K; AMDISEN A
Psychopharmacologia; 1964 Mar; 5():301-5. PubMed ID: 14143342
[No Abstract] [Full Text] [Related]
29. [CORRECTION BY ETYBENZATROPINE OF EXTRAPYRAMIDAL SYMPTOMS DUE TO NEUROLEPTICS].
BORENSTEIN P; BLES G
Presse Med (1893); 1964 May; 72():1595-6. PubMed ID: 14149342
[No Abstract] [Full Text] [Related]
30. [REPERCUSSIONS OF NEUROLEPTIC AND ANTITUMOR AGENTS ON PRENATAL DEVELOPMENT].
TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
Bull Schweiz Akad Med Wiss; 1964 Sep; 20():490-526. PubMed ID: 14192394
[No Abstract] [Full Text] [Related]
31. [EVALUATION OF THE VASODILATOR EFFECT OF INTRA-ARTERIAL MYDETON IN DOGS].
KELLER L; MOLNAR G; ZULIK R
Orv Hetil; 1964 Feb; 105():250-1. PubMed ID: 14139726
[No Abstract] [Full Text] [Related]
32. THROMBOEMBOLIC COMPLICATIONS IN NEUROLEPTIC TREATMENT.
HAEFNER H; BREHM I
Compr Psychiatry; 1965 Feb; 6():25-34. PubMed ID: 14271834
[No Abstract] [Full Text] [Related]
33. [Disipal and the correction of parkinsonism induced by neuroleptics. (A critical review)].
MEURICE E
Acta Neurol Psychiatr Belg; 1961 Jan; 61():47-66. PubMed ID: 13769933
[No Abstract] [Full Text] [Related]
34. SIDE REACTIONS TO THE PHENOTHIAZINES AND THE THERAPEUTIC USE OF ETHYL ALCOHOL.
LERNER J
Am J Psychiatry; 1965 Mar; 121():919-20. PubMed ID: 14264771
[No Abstract] [Full Text] [Related]
35. [MEDICAL TREATMENT OF PARKINSON'S DISEASE].
STRANG RR
Sven Lakartidn; 1964 Sep; 61():2694-713. PubMed ID: 14231565
[No Abstract] [Full Text] [Related]
36. Theoretical considerations in parkinsonism induced by tranquilizing drugs.
GUGGENHEIM P; COHEN L
Dis Nerv Syst; 1959 Aug; 20():346-52. PubMed ID: 13830100
[No Abstract] [Full Text] [Related]
37. PARKINSONISM: AETIOLOGY AND TREATMENT.
TURNER JW
Lond Clin Med J; 1964 Jan; 5():41-9. PubMed ID: 14108041
[No Abstract] [Full Text] [Related]
38. Successful use of mydocalm in peripheral arterial disease.
MOLNAR L
Ther Hung; 1962; 10():10-2. PubMed ID: 13935926
[No Abstract] [Full Text] [Related]
39. REVIEW OF ANTIMOTION SICKNESS DRUGS FROM 1954-1964.
WOOD CD; KENNEDY RS; GRAYBIEL A
Aerosp Med; 1965 Jan; 36():1-4. PubMed ID: 14243672
[No Abstract] [Full Text] [Related]
40. SOME REMARKS ON THE TREATMENT OF POST-ENCEPHALITIC OCULOGYRIC CRISES WITH BENZTROPINE METHANESULFONATE.
PAULSON G; BUFFALOE WJ
Int J Neuropsychiatry; 1965; 1():214-5. PubMed ID: 14309084
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
